Sutro Biopharma, Inc. (STRO)
22.50
+1.19
(+5.58%)
USD |
NASDAQ |
Mar 05, 16:00
22.48
-0.02
(-0.09%)
After-Hours: 20:00
Sutro Biopharma Research and Development Expense (Annual) : 252.04M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| GT Biopharma, Inc. | 3.472M |
| Rhythm Pharmaceuticals, Inc. | 166.90M |
| Crinetics Pharmaceuticals, Inc. | 328.17M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |